Streetbeat News

Earnings

GEL

Genesis Energy (NYSE:GEL) reported a Q1 2024 GAAP EPS of $(0.09) and sales of $770.105M, marking a 2.59% decrease from $790.612M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:02 am

XRAY

Dentsply Sirona reported Q1 2024 adjusted earnings per share of $0.42, meeting analyst expectations, but missed sales estimates with $953 million against the expected $969.136 million. This represents a 7.69% increase in earnings and a 2.56% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:02 am

SWK

Stanley Black & Decker reported Q1 2024 adjusted EPS of $0.56, surpassing the $0.54 estimate, with sales of $3.869B also beating the $3.823B estimate, despite a 1.59% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:02 am

LAMR

Lamar Advertising (NASDAQ:LAMR) reported Q1 earnings of $0.76 per share, missing the consensus estimate of $0.81 by 6.17%, but saw a 2.7% increase from last year's earnings. Sales reached $498.15M, exceeding estimates by 1.49% and marking a 5.69% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

CGNX

Cognex reported Q1 2024 adjusted EPS of $0.11, surpassing the $0.08 estimate, with sales of $210.797M also beating the $200.419M forecast. This represents a 4.81% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

CI

Cigna Group (NYSE:CI) reported Q1 2024 adjusted EPS of $6.47, surpassing the $6.37 estimate, and sales of $57.255B, exceeding the $55.471B estimate. This represents a 19.59% increase in earnings and a 23.08% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

AUPH

Aurinia Pharmaceuticals reported Q1 2024 earnings with a GAAP EPS of $(0.07), surpassing the $(0.14) estimate. Sales reached $50.3M, exceeding the $47.453M forecast, marking a 46.18% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

CHT

Chunghwa Telecom (NYSE:CHT) reported a decrease in Q1 earnings per share to $0.39 from $0.41 YoY and a sales decline to $1.75B from $1.78B YoY, indicating a slight downturn in performance.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:51 am

CTLT

LLY

NVO

Novo Nordisk A/S (NVO) is experiencing a significant increase in U.S. patients starting on its weight-loss drug, Wegovy, despite facing supply constraints and competition from Eli Lilly & Co. (LLY). Wegovy sales more than doubled in the first quarter, reaching $1.35 billion, although this was below analysts' expectations. Novo Nordisk is doubling its manufacturing investment to $6.4 billion, not including an $11 billion acquisition of factories from Catalent Inc. (CTLT). The company is also expanding Wegovy's market to Japan and expects sales and operating profit to surge by up to 27% and 30%, respectively, this year. However, pricing pressures and regulatory challenges in the U.S. and Denmark are affecting the company.

Portfolio Pulse from Benzinga Neuro

May 02, 2024 | 9:48 am

ASPN

CVNA

EBS

FRSH

FSLY

Aspen Aerogels, Inc. (ASPN) shares surged 26% in pre-market trading after reporting Q1 financial results that exceeded expectations, with a smaller loss and higher sales than forecasted. Other stocks also showed significant pre-market movements, including notable gainers like Emergent BioSolutions (EBS) and Carvana Co. (CVNA), and losers such as Fastly, Inc. (FSLY) and Freshworks Inc. (FRSH), following their respective earnings reports and company announcements.

Portfolio Pulse from Avi Kapoor

May 02, 2024 | 9:43 am